Yu R. Choi
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson's disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 21, 2023
Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 20, 2022
Molecular events underlying the cell-to-cell transmission of α-synuclein.
Journal: The FEBS journal
Published: August 31, 2020
The dual role of c-src in cell-to-cell transmission of α-synuclein.
Journal: EMBO reports
Published: July 04, 2020
The dual role of c-src in cell-to-cell transmission of α-synuclein.
Journal: EMBO reports
Published: July 25, 2019
Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.
Journal: Molecular neurodegeneration
Published: September 25, 2015
FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
Journal: Neurobiology of disease
Published: April 27, 2015
Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.
Journal: The Journal of biological chemistry
Published: May 24, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026